Literature DB >> 24853528

Withdrawal times of oxytetracycline and tylosin in eggs of laying hens after oral administration.

Rubén Muñoz1, Javiera Cornejo2, Aldo Maddaleno1, Carolina Araya-Jordán1, Daniela Iragüen1, Nicolás Pizarro1, Betty San Martín3.   

Abstract

Antimicrobials administered to laying hens may be distributed into egg white or yolk, indicating the importance of evaluating withdrawal times (WDTs) of the pharmaceutical formulations. In the present study, oxytetracycline and tylosin's WDTs were estimated. The concentration and depletion of these molecules in eggs were linked to their pharmacokinetic and physicochemical properties. Twenty-seven Leghorn hens were used: 12 treated with oxytetracycline, 12 treated with tylosin, and 3 remained as an untreated control group. After completion of therapies, eggs were collected daily and drug concentrations in egg white and yolk were assessed. The yolk was used as the target tissue to evaluate the WDT; the results were 9 and 3 days for oxytetracycline and tylosin, respectively. In particular, oxytetracycline has a good oral bioavailability, a moderate apparent volume of distribution, a molecular weight of 460 g/mol, and is lightly liposoluble. Tylosin, a hydrosoluble compound, with a molecular weight of 916 g/mol, has a low oral bioavailability and a low apparent volume of distribution, too. Present results suggest that the WDTs of the studied antimicrobials are strongly influenced by their oral bioavailability, the distribution, and the molecular weight and solubility, and that these properties also influence the distribution between the egg yolk and white.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24853528     DOI: 10.4315/0362-028X.JFP-13-440

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  1 in total

1.  Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.

Authors:  Lingli Huang; Haiyang Zhang; Mei Li; Ijaz Ahmad; Yulian Wang; Zonghui Yuan
Journal:  BMC Vet Res       Date:  2018-10-24       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.